Coloplast A/S logo

COLO B - Coloplast A/S Share Price

DKK1065.5 -14.0  -1.3%

Last Trade - 2:56pm

Sector
Healthcare
Size
Large Cap
Market Cap £27.87bn
Enterprise Value £28.16bn
Revenue £2.27bn
Position in Universe 15th / 1782
Bullish
Bearish
Unlock COLO B Revenue
Momentum
Relative Strength (%)
1m +9.63%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -6.01%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
12,428 13,909 14,681 15,528 16,449 17,939 19,081 20,738 +7.6%
+12.1 -2.6 +20.7 +2.5 +1.9 +8.2 +5.67 +13.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 March 2020, Coloplast A/S revenues increased 9% to DKR9.54B. Net income increased 7% to DKR2.16B. Revenues reflect Chronic Care segment increase of 10% to DKR7.29B, Wound & Skin Care segment increase of 8% to DKR1.2B, Interventional Urology segment increase of 8% to DKR1.04B, European Markets segment increase of 7% to DKR5.59B, Other Developed Markets segment increase of 14% to DKR2.35B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for COLO B
Graphical History

Revenue

COLO B Revenue Unlock COLO B Revenue

Net Income

COLO B Net Income Unlock COLO B Revenue

Normalised EPS

COLO B Normalised EPS Unlock COLO B Revenue

PE Ratio Range

COLO B PE Ratio Range Unlock COLO B Revenue

Dividend Yield Range

COLO B Dividend Yield Range Unlock COLO B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
COLO B EPS Forecasts Unlock COLO B Revenue
Profile Summary

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.

Directors
Last Annual September 30th, 2019
Last Interim March 31st, 2020
Incorporated September 4, 1957
Public Since January 1, 1983
No. of Shareholders: 39,452
No. of Employees: 12,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSEurofirst 300 Health Care Equipment & Services , FTSEurofirst 300 , FTSEurofirst 300 Ex Eurozone, FTSEurofirst 300 Ex UK,
Exchange OMX Nordic Exchange - Copenhagen
Shares in Issue 212,849,549
Free Float (0.0%)
Eligible for
ISAs
SIPPs
COLO B Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for COLO B
Upcoming Events for COLO B
Tuesday 18th August, 2020
Q3 2020 Coloplast A/S Earnings Release
Tuesday 18th August, 2020
Q3 2020 Coloplast A/S Earnings Call
Wednesday 19th August, 2020
Coloplast A/S at Carnegie Investment Bank AB Roadshow - Copenhagen
Thursday 20th August, 2020
Coloplast A/S at Barclays PLC Virtual Roadshow - UK
Thursday 27th August, 2020
Coloplast A/S at SEB Nordic Large Cap Seminar (Virtual)
Friday 28th August, 2020
Coloplast A/S at JPMorgan CEO Conference Call Series
Tuesday 1st September, 2020
Coloplast A/S at Commerzbank Sector Conference
Wednesday 2nd September, 2020
Coloplast A/S at ABG Sundal Collier Large Cap Seminar
Wednesday 9th September, 2020
Coloplast A/S at Goldman Sachs European Medtech and Healthcare Services Conference
Thursday 10th September, 2020
Coloplast A/S at Kepler Cheuvreux Autumn Conference (Virtual)
Monday 14th September, 2020
Coloplast A/S at Morgan Stanley Global Healthcare Conference (Virtual)
Wednesday 16th September, 2020
Coloplast A/S at Handelsbanken Capital Markets Innovation Seminar
Friday 18th September, 2020
Coloplast A/S at Bank of America Merrill Lynch Global Healthcare Conference
Wednesday 23rd September, 2020
Coloplast A/S at Sanford C Bernstein Strategic Decisions Conference
Wednesday 23rd September, 2020
Coloplast A/S at GPW, NN Investment Partners, CFA Society Poland and Erste Securities ESG Warsaw Conference (Virtual)
Friday 2nd October, 2020
Coloplast A/S at ABG Sundal Collier General Update Conference Call
Tuesday 3rd November, 2020
Q4 2020 Coloplast A/S Earnings Call
Tuesday 3rd November, 2020
Q4 2020 Coloplast A/S Earnings Release
Tuesday 10th November, 2020
Coloplast A/S at Exane Bnp Paribas MedTech CEO Conference
Monday 30th November, 2020
Coloplast A/S at Berenberg European Conference
Frequently Asked Questions for Coloplast A/S
What is the Coloplast A/S share price?

As of 2:56pm, shares in Coloplast A/S are trading at DKK1065.5, giving the company a market capitalisation of £27.87bn. This share price information is delayed by 15 minutes.

How has the Coloplast A/S share price performed this year?

Shares in Coloplast A/S are currently trading at DKK1065.5 and the price has moved by 36.3% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Coloplast A/S price has moved by 42.34% over the past year.

What are the analyst and broker recommendations for Coloplast A/S?

Of the analysts with advisory recommendations for Coloplast A/S, there are there are currently 2 "buy" , 10 "hold" and 4 "sell" recommendations. The overall consensus recommendation for Coloplast A/S is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Coloplast A/S next release its financial results?

Coloplast A/S is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Coloplast A/S dividend yield?

The Coloplast A/S dividend yield is 1.57% based on the trailing twelve month period.

Does Coloplast A/S pay a dividend?

Last year, Coloplast A/S paid a total dividend of 17, and it currently has a trailing dividend yield of 1.57%. Looking ahead, Coloplast A/S has not announced an ex-dividend date yet.

When does Coloplast A/S next pay dividends?

Coloplast A/S has yet to annouce their ex-dividend date. The historic dividend yield on Coloplast A/S shares is currently 1.57%.

How do I buy Coloplast A/S shares?

To buy shares in Coloplast A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Coloplast A/S?

Shares in Coloplast A/S are currently trading at DKK1065.5, giving the company a market capitalisation of £27.87bn.

Where are Coloplast A/S shares listed? Where are Coloplast A/S shares listed?

Here are the trading details for Coloplast A/S:

Country of listing: Denmark
Exchange: CPH
Ticker Symbol: COLO B
What kind of share is Coloplast A/S?

Based on an overall assessment of its quality, value and momentum, Coloplast A/S is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Coloplast A/S share price forecast 2020?

Shares in Coloplast A/S are currently priced at DKK1065.5. At that level they are trading at 12.82% premium to the analyst consensus target price of 0.00.

Analysts covering Coloplast A/S currently have a consensus Earnings Per Share (EPS) forecast of 20.897 for the next financial year.

How can I tell whether the Coloplast A/S share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Coloplast A/S. Over the past six months, the relative strength of its shares against the market has been 40.91%. At the current price of DKK1065.5, shares in Coloplast A/S are trading at 15.16% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Coloplast A/S PE Ratio?

The Coloplast A/S PE ratio based on its reported earnings over the past 12 months is 52.78. The shares are currently trading at DKK1065.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Coloplast A/S?

Coloplast A/S's management team is headed by:

Niels Louis-Hansen - VCH
Lars Rasmussen - CHM
Thomas Barfod - DRC
Torben Rasmussen - DRC
Allan Rasmussen - COO
Kristian Villumsen - PRE
Nicolai Buhl Andersen - SVP
Oliver Johansen - SVP
Steffen Hovard - SVP
Anders Lonning-Skovgaard - CFO
Paul Marcun - EVP
Martin Gioertz Mueller - DRC
Birgitte Nielsen - IND
Rasmus Hannemann - SVP
Carsten Hellmann - IND
Nikolaj Kyhe Gundersen - DRC
Roland Vendelbo Pedersen - DRC
Who are the major shareholders of Coloplast A/S?

Here are the top five shareholders of Coloplast A/S based on the size of their shareholding:

Louis-Hansen (Niels Peter) Individual Investor
Percentage owned: 20.7% (41.0m shares)
Aage og Johanne Louis-Hansens Fond Corporation
Percentage owned: 11.4% (22.6m shares)
Find (Benedicte) Individual Investor
Percentage owned: 3.7% (7.33m shares)
Fundsmith Equity Fund Mutual Fund
Percentage owned: 2.17% (4.30m shares)
Fundsmith LLP Investment Advisor
Percentage owned: 2.17% (4.30m shares)
Similar to COLO B
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.